KEAP1 and cancer: Previous studies indicated activation of the ROS-scavenging signal (e.g., Keap1-Nrf2-ARE pathway) and deregulation of anti-oxidant enzymes (PRDX, GPxs, TrxRs, and MnSOD) in CP-resistant cancer cells 50-52.